Position in MRNA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$7,003
+$5,712 QoQ
Shares Held
100
+100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#653
of 772 holders
Holding Since
Dec 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Colonial Trust Advisors holds $281,628 across 10 Biotechnology names. MRNA ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
224 | $111,267 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
5,425 | $47,495 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
61 | $38,035 | |
| 4 | SLS |
SELLAS Life Sciences Group, Inc.
|
2,516 | $37,136 | |
| 5 | ARGX |
Argenx SE
|
17 | $15,772 | |
| 6 | SRPT |
Sarepta Therapeutics, Inc.
|
700 | $12,579 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
209 | $11,398 | |
| 8 | MRNA |
Moderna, Inc.
This page
|
100 | $7,003 |
All Filings in MRNA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,003 | 100 | Shares | Sole | 2026-08-11 | |
| 2025-09-30 | $1,291 | 50 | Shares | Sole | 2025-11-10 | |
| 2024-03-31 | $745 | 7 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,690 | 17 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $309 | 3 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,215 | 10 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,918 | 19 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,131 | 23 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||